HGF and hepatocellular carcinoma: The one-armed anti-c-MET antibody 2E6 successfully blocked the interaction between HGF and c-MET, thereby inhibiting subsequent signal transduction events such as the phosphorylation of c-MET, GAB1, ERK1/2, and AKT in the HepG2 HCC cell line.